Given that weight regain is the likely outcome of these weight loss methods [10, 12, 13], and that widespread weight regain after GLP-1 cessation may become increasingly common, it is crucial to understand the social consequences of weight regain
Shima Hadidchi and her team recommend using Zepbound as part of a comprehensive, medically supervised weight management plan
Both represent transformative advances in metabolic health
Many patients do well long-term at 5 to 10 mg tirzepatide or 1.0 to 1.7 mg semaglutide
Already, at least 1 in 8 American adults [archived link] have taken a GLP-1 and more than half would qualify to take one, according to the latest estimates [archived link]
Peptides for Weight Loss: Research Compounds Compared Side-by-side research comparison of the leading weight-loss peptides studied in US laboratories mechanism, half-life, and documentation